Mass Tort Marketing for Law Firms: Building a Sustainable Client Acquisition Strategy

Mass tort marketing operates on a different scale and timeline than traditional personal injury advertising, and firms that treat it the same way they treat local PI marketing tend to burn through budget without building the sustainable pipeline mass tort litigation actually requires. Because mass tort cases frequently involve years-long litigation cycles, large plaintiff pools, and highly competitive media environments once a docket gains national attention, a sustainable client acquisition strategy has to account for case selection discipline, compliance requirements that vary by jurisdiction, and an intake operation capable of handling volume spikes without letting signed retainer quality slip. This guide walks through the core building blocks firms need to construct a mass tort marketing strategy that holds up over the full life of a litigation, not just its first few weeks.

The firms that sustain profitable mass tort practices over multiple docket cycles tend to share a common trait: they treat marketing as one component of a broader operational system rather than an isolated function handled independently from litigation strategy, intake, and case management. A marketing campaign that generates strong lead volume but overwhelms an unprepared intake team, or that attracts claimants who don't match the docket's actual eligibility criteria, doesn't just underperform on its own terms; it can actively strain firm resources and damage the firm's ability to properly serve the genuinely qualified clients it does sign. Building sustainability requires coordinating all of these moving pieces from the outset, ideally with regular communication between marketing leadership and the attorneys and staff actually handling the resulting caseload.

Starting With Disciplined Case Selection

Every mass tort marketing strategy has to start before a single ad ever runs, with a clear-eyed assessment of which litigation dockets are actually worth pursuing. Not every emerging mass tort is a good fit for every firm, and case selection should weigh factors like the strength of the underlying scientific or medical evidence, the size of the realistic plaintiff pool, how many firms are already actively marketing for the same docket, and whether a firm has the litigation infrastructure, or a reliable co-counsel relationship, to actually handle the caseload it might generate. Firms that chase every emerging docket regardless of fit tend to spread marketing dollars too thin across cases that never develop the settlement value or plaintiff volume marketing spend assumed.

A disciplined case selection process typically involves input from both marketing and litigation leadership within a firm, rather than leaving the decision entirely to whichever department notices an emerging docket first. Marketing leadership brings a clear-eyed view of realistic acquisition costs and competitive intensity, while litigation leadership brings judgment about the underlying evidence strength and the firm's actual capacity to handle the resulting caseload well. Firms that build this cross-functional review into their case selection process tend to avoid the common failure pattern of marketing chasing a docket that litigation leadership later concludes isn't strong enough to justify the resources already spent generating case volume.

Building a Multi-Channel Media Mix

Successful mass tort marketing rarely relies on a single channel, both because plaintiff populations for a given docket are often spread across different demographics and media consumption habits, and because concentrating spend in one channel makes a campaign vulnerable to sudden cost spikes as competition intensifies. National television remains a significant channel for high-profile dockets, but digital channels, including paid search, programmatic display, and connected television, have become increasingly important as firms compete for the same limited pool of potential claimants across every screen those claimants use. A well-constructed media mix typically layers broad-reach channels for initial awareness with more targeted digital channels designed to capture and convert people who are already actively searching for information about a specific product or exposure.

The right mix also shifts over the life of a docket rather than staying fixed from launch through resolution. Early in a docket's public awareness cycle, broader-reach channels tend to do more of the work introducing the litigation to a population that may not yet know they have a potential claim, while later in the cycle, once public awareness has built through media coverage and other firms' campaigns, paid search and other high-intent digital channels often become more efficient as more of the addressable population has already become aware of the litigation and is actively searching for information rather than needing to be introduced to it for the first time.

Radio and print advertising still play a meaningful role for certain claimant demographics, particularly older populations who may be overrepresented in some pharmaceutical or medical device dockets and who consume media differently than younger audiences more reachable through digital and connected television channels. Firms that build their media mix around a realistic understanding of the specific docket's likely claimant demographics, rather than defaulting to whatever channel mix worked for a previous, demographically different docket, tend to achieve better cost efficiency than firms applying an identical media strategy across every campaign regardless of the underlying audience. Testing a modest budget across an underused channel before committing significant spend helps firms validate these demographic assumptions with real data rather than relying purely on intuition.

• National or regional television for high-volume awareness campaigns on well-established dockets.
• Paid search targeting high-intent queries from people already searching for information about a specific case.
• Connected television and streaming platforms to reach audiences shifting away from traditional broadcast.
• Referral and co-counsel networks that supplement paid media with pre-vetted case flow.
• Owned content and SEO assets that continue generating inquiries well after paid campaigns wind down.

Navigating Mass Tort Advertising Compliance

Compliance requirements for mass tort advertising vary meaningfully by state and by the specific claims made in an ad, and firms running national campaigns need legal review processes robust enough to catch jurisdiction-specific issues before they become a bar complaint or a media platform rejection. Common compliance pitfalls include making claims that could be read as guaranteeing outcomes, using medical or scientific language that oversteps what current litigation actually supports, and failing to include required attorney advertising disclosures that differ from state to state. Firms running mass tort campaigns at scale typically build a standing compliance review process into their creative approval workflow rather than treating legal review as an afterthought applied only after creative is already finalized.

Media platforms themselves have also become more active gatekeepers of mass tort advertising content, with television networks, search engines, and social media platforms applying their own review standards on top of state bar advertising rules, particularly for medical and pharmaceutical-related claims. Firms should budget extra time in their campaign launch timeline for this platform-level review process, since creative that clears a firm's internal legal review can still get flagged or delayed by a media platform's own compliance team, and building this expectation into campaign planning from the outset avoids launch delays that can meaningfully affect a campaign's competitive positioning against other firms marketing for the same docket.

Calculating Cost Per Signed Retainer, Not Just Cost Per Lead

Cost per lead is a common metric in mass tort marketing reporting, but it obscures more than it reveals if a firm isn't also tracking cost per signed retainer, since raw lead volume means very little if a large share of those leads fail to qualify or never sign. A campaign generating leads at a low cost per lead but converting only a small fraction into retained clients can easily end up more expensive on a true acquisition-cost basis than a campaign with a higher cost per lead but meaningfully better qualification and conversion rates. Firms serious about sustainable mass tort marketing build reporting dashboards around cost per signed retainer as the primary efficiency metric, using cost per lead mainly as a secondary, diagnostic number.

This distinction matters even more in mass tort marketing than in general personal injury marketing, because mass tort campaigns often generate a much wider range of inquiry quality, from claimants who clearly meet every eligibility criterion to claimants who saw a compelling ad but don't actually have a viable claim once screened. Firms that only track cost per lead risk continuing to fund channels that generate high volumes of exactly this second category, while firms tracking cost per signed retainer catch this problem quickly and can redirect spend toward channels or creative approaches that attract a genuinely higher-intent, better-qualified audience from the outset.

Building an Intake System That Can Absorb Volume Spikes

Mass tort marketing campaigns can generate sudden, dramatic spikes in inbound inquiries, particularly around major news coverage of a settlement, FDA action, or court ruling related to a given docket, and an intake system built for a firm's normal day-to-day PI caseload often buckles under that kind of volume. Firms that market mass tort cases at scale typically build intake capacity with deliberate slack built in, whether through overflow staffing arrangements, call center partnerships, or intake software configured specifically to handle mass tort qualification criteria, so that a sudden surge in inbound leads doesn't translate into a sudden surge in lost, unqualified, or improperly screened potential clients.

Building this kind of elastic intake capacity requires planning well before a campaign launches, not scrambling to add staff once inquiry volume has already exceeded what the current team can handle. Firms that run mass tort campaigns successfully at scale typically maintain standing relationships with intake outsourcing partners they can activate quickly when a campaign is expected to generate a significant volume spike, along with cross-trained internal staff who can shift temporarily into mass tort intake support during peak periods without completely abandoning their normal responsibilities elsewhere in the firm.

Tracking the Metrics That Actually Predict Sustainability

Beyond cost per signed retainer, firms running sustainable mass tort marketing programs track a broader set of metrics that reveal whether a campaign is actually building durable case inventory or just generating expensive noise. This includes qualification rate by channel and by creative, time from initial inquiry to signed retainer, attrition rate of signed clients who later fail to meet final case criteria after deeper medical record review, and the ongoing cost trend for a given docket as more firms enter the marketing landscape. Firms that build this level of analytics discipline into mass tort marketing tend to make faster, better-informed decisions about when to scale a campaign up, hold steady, or pull back.

Attrition rate deserves particular attention because it's frequently underweighted in firms' initial marketing analysis, even though it can dramatically affect true case economics. A client who signs a retainer based on an initial phone screening but is later dropped after full medical record review reveals a case type or exposure history that doesn't actually meet the docket's requirements represents a real cost, both the marketing spend and intake time already invested and the opportunity cost of resources not spent pursuing a genuinely viable claimant instead. Firms that track this attrition rate by lead source can identify which channels tend to produce leads that hold up under deeper scrutiny versus channels producing leads that look promising initially but frequently don't survive final qualification.

• Cost per signed retainer, tracked by channel, creative, and time period.
• Qualification rate from initial inquiry through final case acceptance.
• Time from lead to signed retainer, and from signed retainer to final qualification.
• Attrition rate of clients who sign but are later dropped after full medical record review.
• Trending cost per lead over the life of the docket as competitive intensity shifts.

Working With Co-Counsel and Referral Partners

Many firms running mass tort marketing campaigns don't handle the full litigation independently, instead referring or jointly handling signed cases with a larger co-counsel firm that has deeper litigation infrastructure for a given docket. When marketing is built around this kind of referral relationship, the same disciplined approach to case selection and compliance still applies, but firms also need clear agreements with co-counsel partners about qualification standards, fee splits, and communication expectations, so that a signed client experiences a smooth transition rather than confusion about which firm is actually handling their case going forward.

These referral relationships can also meaningfully expand a firm's effective marketing reach, since a smaller firm without the budget to run a large independent campaign can still participate in a docket's marketing and intake process as part of a co-counsel arrangement, sharing both the cost of client acquisition and the resulting caseload with a partner firm. Firms considering this model should vet potential co-counsel partners as carefully as they would vet a lead vendor, confirming litigation track record, communication practices, and financial stability before committing to a shared marketing and referral arrangement. A well-structured co-counsel relationship, documented clearly in writing from the outset, tends to hold up far better under the pressure of a multi-year litigation than an informal handshake arrangement negotiated quickly to capitalize on an emerging docket. Firms new to co-counsel arrangements should also request references from other firms that have worked with a prospective partner, applying the same due diligence they'd apply when vetting any other significant vendor relationship.

Deciding When to Scale a Campaign Up or Down

Mass tort litigation timelines rarely move in a straight line, and marketing spend needs to be flexible enough to respond to major developments, whether that's an MDL formation that clarifies a docket's viability, a bellwether trial outcome that shifts settlement expectations, or a competitive landscape that suddenly gets more crowded and expensive as other firms notice the same opportunity. Firms with the strongest long-term mass tort marketing programs build regular checkpoints into their planning process, reviewing docket developments and campaign performance on a set cadence rather than reacting only when a problem becomes impossible to ignore.

These checkpoints work best when they combine internal performance data with external litigation intelligence, since a campaign's cost per signed retainer might look stable even as underlying litigation developments quietly shift the docket's long-term settlement prospects in a way that won't show up in marketing metrics until much later. Firms that maintain close relationships with litigation counsel, co-counsel partners, or industry publications tracking a given docket's progress are better equipped to make proactive scaling decisions rather than reactive ones driven purely by marketing performance data that inherently lags behind the underlying litigation's actual trajectory.

Sustainable mass tort marketing ultimately comes down to treating client acquisition as a disciplined system rather than a single opportunistic bet on whichever docket is generating the most headlines this quarter. Firms that combine careful case selection, a diversified media mix, rigorous compliance review, and intake infrastructure built for volume tend to outlast competitors chasing the same dockets with less structure behind their approach, and they're better positioned to weather the inevitable ups and downs that come with any multi-year mass tort litigation. Firms without the internal marketing infrastructure to run this kind of program can still participate in mass tort case acquisition through Eilite's legal lead marketplace, which connects firms with vetted case flow without requiring an in-house media buying operation.